These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 843964)

  • 41. [Use of turinal in the combined treatment of threatened abortion and its effect on placental hormone function].
    Kosheleva NG; Svechnikova FA; Golumb SB
    Akush Ginekol (Mosk); 1981 May; (5):23-5. PubMed ID: 7306358
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical use of Intaserin for the therapy of premature labor and abortion].
    Izuchi S; Kuga S; Yamashita H
    Sanfujinka No Jissai; 1969 Feb; 18(2):181-4. PubMed ID: 5818866
    [No Abstract]   [Full Text] [Related]  

  • 43. [The incidence of congenital abnormalities following gestagen administration in early pregnancy (author's transl)].
    Schneider WH; Philipp K; Schmid R
    Wien Klin Wochenschr; 1981 Dec; 93(23):711-2. PubMed ID: 7342466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Indications of hormonal therapy in early pregnancy (author's transl)].
    Dvorák K
    Cesk Gynekol; 1973 Nov; 38(9):651-2. PubMed ID: 4765151
    [No Abstract]   [Full Text] [Related]  

  • 45. [Assessment of the obstetric application of 17-hydroxyprogesterone capronate (Hormofort)].
    Németi S; Veres L; Balázsy T; Surányi S
    Orv Hetil; 1970 Jun; 111(24):1404-7. PubMed ID: 5454025
    [No Abstract]   [Full Text] [Related]  

  • 46. [Management in threatened abortions (author's transl)].
    Magnin P
    J Gynecol Obstet Biol Reprod (Paris); 1978 Apr; 7(3 Pt 2):663-4. PubMed ID: 701748
    [No Abstract]   [Full Text] [Related]  

  • 47. [Is hormonal therapy still justified in imminent abortion? (author's transl)].
    Berle P; Budenz M; Michaelis J
    Z Geburtshilfe Perinatol; 1980 Oct; 184(5):353-8. PubMed ID: 7197091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evaluation of therapeutic results of gestagen preparations in imminent abortion and preterm deliveries (author's transl)].
    Vierik J; Bruchác D; Handzo I; Ruttkayová A; Ponecová M
    Bratisl Lek Listy; 1980 Sep; 74(3):347-53. PubMed ID: 7417872
    [No Abstract]   [Full Text] [Related]  

  • 49. [How to stimulate the placental function (author's transl)].
    Fanard A; Picazo JJ
    Reproduccion; 1976; 3(1-2):15-25. PubMed ID: 1027640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Experience with shirodkar's suturing (author's transl)].
    Wolf H; Hauser GA
    Ther Umsch; 1978 Jun; 35(6):426-44. PubMed ID: 354074
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of turinal and progesterone combined with chorionic gonadotropin on cellular immunity during the treatment of threatened abortion in the first and second trimesters].
    Zhuchenko PG; Lisovskaia TV; Gordiĭchuk VD
    Akush Ginekol (Mosk); 1988 Dec; (12):24-7. PubMed ID: 3266544
    [No Abstract]   [Full Text] [Related]  

  • 52. [Habitual abortion: diagnostics and therapy in gynaecological practice (author's transl)].
    Gerhard I; von Wendt A; von Holst T; Runnebaum B
    Geburtshilfe Frauenheilkd; 1981 Nov; 41(11):797-803. PubMed ID: 6914995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diagnostic and therapy of the asherman's syndrome (author's transl)].
    Poradovský K; Lukacín S
    Cesk Gynekol; 1975 Aug; 40(7):502-3. PubMed ID: 1236774
    [No Abstract]   [Full Text] [Related]  

  • 54. [Serum hCG, hPL and progesterone levels in threatened abortions (author's transl)].
    Sugita N; Yamaji K; Fujita M; Chiba Y; Otsuki Y; Takagi T; Tanizawa O; Kurachi K; Sasaki K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):851-8. PubMed ID: 7240863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pilot study into habitual abortion (author's transl)].
    Gerl D; Krauss A; Robel R
    Zentralbl Gynakol; 1980; 102(2):93-8. PubMed ID: 7467960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Status of the feto-placental system in pregnant women with a history of habitual abortion during complex therapy including metabolic correction].
    Mamedalieva NM; Burlev VA; Sitnikov VF; Sidel'nikova VM; Volobuev AI; Zykin BI
    Akush Ginekol (Mosk); 1991 Jul; (7):22-6. PubMed ID: 1951965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of premature labour and antagonization of the side effects of tocolytic therapy with verapamil (author's transl)].
    Gummerus M
    Z Geburtshilfe Perinatol; 1977 Oct; 181(5):334-40. PubMed ID: 605642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [On the use of fenoterolhydrobromide in the treatment of imminent abortion (author's transl)].
    Ruppin E; Eberhard F; Chelius HH
    Geburtshilfe Frauenheilkd; 1978 Jun; 38(6):461-7. PubMed ID: 669234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Preventive administration of gestagen in early pregnancy after the treatment of functional anovulatory sterility (author's transl)].
    Dvorák K
    Cesk Gynekol; 1977 Oct; 42(9):673-6. PubMed ID: 597891
    [No Abstract]   [Full Text] [Related]  

  • 60. [Acetomepregenol in the treatment of threatened late miscarriages (clinico-experimental study)].
    Boĭkova VV; Martynshin MIa; Murzakmatov MA
    Akush Ginekol (Mosk); 1989 Jun; (6):42-3. PubMed ID: 2774078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.